Results 161 to 170 of about 2,678 (221)

Exploring the Conformational Effects of <i>N</i>- and <i>C</i>-Methylation of <i>N</i>-Acylhydrazones. [PDF]

open access: yesACS Omega
Franco LS   +11 more
europepmc   +1 more source

Evaluation of hydrazone and N-acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer's disease. [PDF]

open access: yesJ Enzyme Inhib Med Chem
Bartolić M   +8 more
europepmc   +1 more source

Iron-Based Nanoparticles as Delivery Tools. [PDF]

open access: yesPharmaceuticals (Basel)
Parang K   +5 more
europepmc   +1 more source

Design, Synthesis, and Bioactivity Assessment of Modified Vemurafenib Analog. [PDF]

open access: yesPharmaceuticals (Basel)
Guerra FS   +5 more
europepmc   +1 more source

A new <i>N</i>-acylhydrazone oxadiazole derivative with activity against mycobacteria. [PDF]

open access: yesFuture Microbiol
Souza IV   +10 more
europepmc   +1 more source

Acylhydrazone derivatives: a patent review

Expert Opinion on Therapeutic Patents, 2014
The N-acylhydrazone (NAH) moiety has been characterized as a privileged structure, capable of providing ligands points for more than one type of bioreceptor. Modifications of the subunits bonded to its acyl and imine functions resulted in several derivatives, which modulate a great diversity of molecular targets.
Rodolfo Do Couto Maia   +2 more
exaly   +3 more sources

N-Acylhydrazones as drugs

Bioorganic & Medicinal Chemistry Letters, 2018
Over the last two decades, N-acylhydrazone (NAH) has been proven to be a very versatile and promising motif in drug design and medicinal chemistry. Herein, we discuss the current and future challenges in the emergence of bioactive NAH-based scaffolds and to developing strategies to overcome the failures in drug discovery. The NAH-related approved drugs
Sreekanth, Thota   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy